Sign inJoin waitlistJoin the waitlist

Megan Jagosky

Co-Associate Leader · Wake Forest University Baptist Medical Center

Credentials: · · · · ·

History

Wake Forest University Baptist Medical Center
Present
Wake Forest University Baptist Medical Center · Wake Forest University School of Medicine
Present

Levine Cancer Institute
2020–2021
Hematology and Medical Oncology
Carolinas Medical Center
2017–2020
Internal Medicine
Carolinas Medical Center
2014–2017
Geisinger Commonwealth School of Medicine
2010–2014

Research

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy
Leukemia · 2019 · 559 citations
Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma
Clinical Cancer Research · 2021 · 71 citations
Extramedullary Disease in Multiple Myeloma
Review · Current Hematologic Malignancy Reports · 2020 · First of 2 authors · 47 citations

CA
Colin Anderson
8 papers
Jeffrey Kneisl
5 papers
Joshua Patt
5 papers
WA
William Ahrens
5 papers
ML
Michael Livingston
4 papers
Saad Usmani
4 papers
Barry Paul
3 papers · 1 as a fellow
Johann Hsu
3 papers
Malcolm Squires
3 papers
AN
Amarendra Neppalli
2 papers
AK
Ankit Kansagra
2 papers
Arjun Lakshman
2 papers · 2 as a resident

Clinical trials

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Principal investigator · Recruiting · Phase 2
Wake Forest University Health Sciences
2026–2033
Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma
Principal investigator · Completed · Phase 2
Wake Forest University Health Sciences
2017–2022